scispace - formally typeset
M

Maciej S. Lesniak

Researcher at Northwestern University

Publications -  303
Citations -  17973

Maciej S. Lesniak is an academic researcher from Northwestern University. The author has contributed to research in topics: Glioma & Oncolytic virus. The author has an hindex of 56, co-authored 271 publications receiving 14773 citations. Previous affiliations of Maciej S. Lesniak include City of Hope National Medical Center & University of Illinois at Chicago.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Biofunctionalized magnetic-vortex microdiscs for targeted cancer-cell destruction

TL;DR: In this paper, a spin-vortex ground state oscillates when activated by an alternating magnetic field, compromising the integrity of the cell membrane and initiating programmed cell death in ∼90% of cancer cells in vitro, even with a low-frequency field applied for only ten minutes.
Journal ArticleDOI

Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors

TL;DR: The therapeutic inhibition of IDO, CTLA-4, and PD-L1 in a mouse model of well-established glioma maximally decreases tumor-infiltrating Tregs, coincident with a significant increase in T-cell–mediated long-term survival.
Journal ArticleDOI

IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival

TL;DR: Clinical and preclinical data confirm that IDO expression increases the recruitment of immunosuppressive Tregs that lead to tumor outgrowth, and IDO deficiency decreases Treg recruitment and enhances T-cell–mediated tumor rejection.